Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women - The effect of body weight reduction by caloric restriction;Veza između adipokina, insulinske osetljivosti i glikoregulacije kod gojaznih žena - Uticaj sniženja telesna mase ograničavanjem kalorija

Vojnosanitetski Pregled

Volumn 70, Issue 3, 2013, Pages 284-291

  Golubović, Milena Velojić ^a   Dimić, Dragan ^a   Antić, Slobodan ^a   Radenković, Saša ^a   Djindjić, Boris ^a   Jovanović, Miodrag ^b  

^a Clinical Center Ni   (Serbia)

^b UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Adiponectin; Body mass index; Diet; Insulin resistance; Leptin; Obesity; Reducing; Women

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; INSULIN; LEPTIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALORIC RESTRICTION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE INDEX; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INSULINEMIA; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT REDUCTION;

EID: 84874593732     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1303284V     Document Type: Article

References (52)

1. Dawber TR. The Framingham Study: the epidemiology of atherosclerotic disease. Cambridge, MA: Harvard University Press; 1980.
2. Kashyap SR, DeFronzo RA. The insulin resistance syndrome: physiological consideration. Diab Vasc Dis Res 2007; 4(1): 13-9.
3. Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, Nolan J, et al. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007; 92(8): 2885-92.
4. Meisinger C, Döring A, Thorand B, Heier M, Löwel H. Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr 2006; 84(3): 483-9.
5. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89(6): 2548-56.
6. Ronti T, Lupattelli G, Mannarino E. The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 2006; 64(4): 355-65.
7. Matsuzawa Y, Shimomura I, Kihara S, Funahashi T. Importance of adipocytokines in obesityrelated diseases. Horm Res 2003; 60(Suppl 3): 56-9.
8. Yang R, Barouch LA. Leptin signaling and obesity: cardiovascular consequences. Circ Res 2007; 101(6): 545-59.
9. Garg A, Misra A. Lipodystrophies: rare disorders causing metabolic syndrome. Endocrinol Metab Clin North Am 2004; 33(2): 305-31.
10. Enriori PJ, Evans AE, Sinnayah P, Cowley MA. Lept in resistance and obesity. Obesity 2006; 14(Suppl 5): S254-8.
11. Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006; 83(2): 461S-5S.
12. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33(Pt 5): 1078-81.
13. Guzik TJ, Mangalat D, Korbut R. Adipocytokinesnovel link between inflammation and vascular function? J Physiol Pharmacol 2006; 57(4): 505-28.
14. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27(11): 2276-83.
15. Wiecek A, Adamczak M, Chudek J. Adiponectinan adipokine with unique metabolic properties. Nephrol Dial Transplant 2007; 22(4): 981-8.
16. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and metaanalysis. JAMA 2009; 302(2): 179-88.
17. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y. Plasma concentrations of a novel, adiposespecific protein, adiponectin in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20(6): 1595-9.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-9.
19. Cohen JW. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
20. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 2004; 89(9): 4206-10.
21. Frühbeck G, Salvador J. Relation between leptin and the regulation of glucose metabolism. Diabetologia 2000; 43(1): 3-12.
22. Ebinç H, Ozkurt ZN, Ebinç FA, Yilmaz M, Caglayan O. Adiponectin and insulin resistance in obesityrelated diseases. J Int Med Res 2008; 36(1): 71-9.
23. Ceddia RB. Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis. Int J Obes (Lond) 2005; 29(10): 1175-83.
24. Chan DC, Watts GF, Ng TW, Uchida Y, Sakai N, Yamashita S, et al. Adiponectin and other adipocytokines as predictors of markers of triglyceriderich lipoprotein metabolism. Clin Chem 2005; 51(3): 578-85.
25. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and ASCVD. Diabetes Care Reviews 1991; 14: 173-94.
26. Dagogo-Jack S, Askari H, Tykodi G. Glucoregulatory physiology in subjects with lownormal, highnormal, or impaired fasting glucose. J Clin Endocrinol Metab 2009; 94(6): 2031-6.
27. Hawkins M, Rossetti L. Insulin resistance and its role in the pathogenesis of type 2 diabetes. In: Kahn RC, Weir GC, King GL, Jacobson AM, Moses AC, editors. Joslińs: Diabetes Medicine. 14th ed. Philadelphia: Saunders-Elsevier; 2006. p. 199-222.
28. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L. Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 2009; 32(2): 281-6.
29. Piché ME, Lemieux S, Pérusse L, Weisnagel SJ. High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes. Diabetologia 2005; 48(4): 732-40.
30. O'Malley G, Santoro N, Northrup V, D'Adamo E, Shaw M, Eldrich S, et al. High normal fasting glucose level in obese youth: a marker for insulin resistance and beta cell dysregulation. Diabetologia 2010; 53(6): 1199-209.
31. Nguyen QM, Srinivasan SR, Xu JH, Chen W, Berenson GS. Changes in risk variables of metabolic syndrome since childhood in prediabetic and type 2 diabetic subjects: the Bogalusa Heart Study. Diabetes Care 2008; 31(10): 2044-9.
32. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med 2008; 121(6): 519-24.
33. Tirosh A, Shai I, Tekes-Manova D, Israeli E, Pereg D, Shochat T, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005; 353(14): 1454-62.
34. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20(4): 537-44.
35. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344(18): 1343-50.
36. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346(6): 393-403.
37. Moore LL, Visioni AJ, Wilson PW, D'Agostino RB, Finkle WD, Ellison RC. Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus? Epidemiology. 2000; 11(3): 269-73.
38. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002; 13(2): 84-9.
39. Sandoval DA, Davis SN. Leptin: metabolic control and regulation. J Diabetes Complications 2003; 17(2): 108-13.
40. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46(4): 459-69.
41. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: crosssectional and interventional studies. J Clin Endocrinol Metab 2003; 88(10): 4823-31.
42. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normalweight and obese women. Eur J Endocrinol 2002; 147(2): 173-80.
43. Park KG, Park KS, Kim MJ, Kim HS, Suh YS, Ahn JD, et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. Diabetes Res Clin Pract 2004; 63(2): 135-42.
44. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003; 11(3): 368-72.
45. Balagopal P, George D, Yarandi H, Funanage V, Bayne E. Reversal of obesityrelated hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J Clin Endocrinol Metab 2005; 90(11): 6192-7.
46. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, et al. Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 2004; 53(3): 585-90.
47. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149(4): 331-5.
48. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116(7): 1784-92.
49. Mazzali G, Di Francesco V, Zoico E, Fantin F, Zamboni G, Benati C, et al. Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women. Am J Clin Nutr 2006; 84(5): 1193-9.
50. Matsubara M, Katayose S, Maruoka S. Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. Eur J Endocrinol 2003; 148(3): 343-50.
51. Zoico E, Di Francesco V, Mazzali G, Vettor R, Fantin F, Bissoli L, et al. Adipocytokines, fat distribution, and insulin resistance in elderly men and women. J Gerontol A Biol Sci Med Sci 2004; 59(9): M935-9.
52. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fatderived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7(8): 941-6.